Tailored Treatments of Fibromyalgia
Launched by UNIVERSITY OF WASHINGTON · Nov 3, 1999
Trial Information
Current as of March 19, 2025
Completed
Keywords
ClinConnect Summary
Fibromyalgia syndrome (FMS) is a prevalent, chronic musculoskeletal pain disorder. Despite extensive study, researchers do not understand well the etiology and pathophysiologic mechanisms of FMS, and have not shown any treatment to be universally effective. We propose that FMS is a complex disorder involving multiple factors, both physical and psychosocial-behavioral.
In our previous research, we demonstrated that FMS patients are heterogeneous in the psychosocial-behavioral axis and can be classified into three distinct subgroups on the basis of their psychosocial adaptation to symptoms. ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Able to visit Seattle based clinic 9 times
- • Meet ACR criteria for FMS
- Exclusion Criteria:
- • Pregnancy
- • Exercise contraindicated by physician due to other medical conditions
- • Significant psychopathology
- • Do not meet FMS criteria
- • Cardiac problems
Trial Officials
Dennis C. Turk, PhD
Principal Investigator
University of Washington
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials